Svas Biosana Past Earnings Performance
Past criteria checks 4/6
Svas Biosana has been growing earnings at an average annual rate of 22.7%, while the Medical Equipment industry saw earnings growing at 9.6% annually. Revenues have been growing at an average rate of 17.4% per year. Svas Biosana's return on equity is 9.3%, and it has net margins of 4.4%.
Key information
22.7%
Earnings growth rate
n/a
EPS growth rate
| Medical Equipment Industry Growth | 8.3% |
| Revenue growth rate | 17.4% |
| Return on equity | 9.3% |
| Net Margin | 4.4% |
| Last Earnings Update | 30 Jun 2024 |
Revenue & Expenses Breakdown
How Svas Biosana makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 124 | 5 | 19 | 0 |
| 31 Mar 24 | 123 | 5 | 19 | 0 |
| 31 Dec 23 | 122 | 5 | 19 | 0 |
| 30 Sep 23 | 117 | 5 | 19 | 0 |
| 30 Jun 23 | 112 | 4 | 19 | 0 |
| 31 Mar 23 | 106 | 4 | 18 | 0 |
| 31 Dec 22 | 100 | 4 | 18 | 0 |
| 30 Sep 22 | 94 | 3 | 15 | 0 |
| 30 Jun 22 | 88 | 3 | 12 | 0 |
| 31 Mar 22 | 85 | 3 | 11 | 0 |
| 31 Dec 21 | 82 | 3 | 11 | 0 |
| 30 Sep 21 | 80 | 3 | 15 | 0 |
| 30 Jun 21 | 79 | 3 | 19 | 0 |
| 31 Mar 21 | 78 | 3 | 15 | 0 |
| 31 Dec 20 | 77 | 3 | 12 | 0 |
Quality Earnings: SVS has a large one-off gain of €1.7M impacting its last 12 months of financial results to 30th June, 2024.
Growing Profit Margin: SVS's current net profit margins (4.4%) are higher than last year (3.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SVS's earnings have grown significantly by 22.7% per year over the past 5 years.
Accelerating Growth: SVS's earnings growth over the past year (31.6%) exceeds its 5-year average (22.7% per year).
Earnings vs Industry: SVS earnings growth over the past year (31.6%) exceeded the Medical Equipment industry 26%.
Return on Equity
High ROE: SVS's Return on Equity (9.3%) is considered low.